Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Johnny C. Hong MD, FACS

Johnny C. Hong MD, FACS

Chief, Associate Professor

Institution: Medical College of Wisconsin
Department: Surgery
Division: Transplant Surgery
Program: Other


  • The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy. (Klintmalm GB, Saab S, Hong JC, Nashan B) Clin Transplant 2014 Jun;28(6):635-48 PMID 24628264
  • Liver transplantation in highest acuity recipients: identifying factors to avoid futility. (Petrowsky H, Rana A, Kaldas FM, Sharma A, Hong JC, Agopian VG, Durazo F, Honda H, Gornbein J, Wu V, Farmer DG, Hiatt JR, Busuttil RW) Ann Surg 2014 Jun;259(6):1186-94 PMID 24263317
  • Liver transplantation in children using organ donation after circulatory death: a case-control outcomes analysis of a 20-year experience in a single center. (Hong JC, Venick R, Yersiz H, Kositamongkol P, Kaldas FM, Petrowsky H, Farmer DG, Agopian V, McDiarmid SV, Hiatt JR, Busuttil RW) JAMA Surg 2014 Jan;149(1):77-82 PMID 24257966
  • The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. (Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW) Ann Surg 2013 Sep;258(3):409-21 PMID 24022434
  • Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival. (Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin TC) HPB (Oxford) 2013 Oct;15(10):794-802 PMID 23782341
  • Liver transplantation for lethal genetic syndromes: a novel model of personalized genomic medicine. (Petrowsky H, Brunicardi FC, Leow VM, Venick RS, Agopian V, Kaldas FM, Zarrinpar A, Markovic D, McDiarmid SV, Hong JC, Farmer DG, Hiatt JR, Busuttil RW) J Am Coll Surg 2013 Apr;216(4):534-43; discussion 543-4 PMID 23521929
  • Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. (Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM) Liver Transpl 2013 Mar;19(3):259-67 PMID 23495079
  • Blood transfusion requirement during liver transplantation is an important risk factor for mortality. (Rana A, Petrowsky H, Hong JC, Agopian VG, Kaldas FM, Farmer D, Yersiz H, Hiatt JR, Busuttil RW) J Am Coll Surg 2013 May;216(5):902-7 PMID 23478547
  • Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. (Yersiz H, Lee C, Kaldas FM, Hong JC, Rana A, Schnickel GT, Wertheim JA, Zarrinpar A, Agopian VG, Gornbein J, Naini BV, Lassman CR, Busuttil RW, Petrowsky H) Liver Transpl 2013 Apr;19(4):437-49 PMID 23408461
  • Doppler US for suspicion of hepatic arterial ischemia in orthotopically transplanted livers: role of central versus intrahepatic waveform analysis. (Choi EK, Lu DS, Park SH, Hong JC, Raman SS, Ragavendra N) Radiology 2013 Apr;267(1):276-84 PMID 23297323
  • Ischaemia-reperfusion injury in liver transplantation--from bench to bedside. (Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW) Nat Rev Gastroenterol Hepatol 2013 Feb;10(2):79-89 PMID 23229329
  • Twenty-four years after liver transplantation, the recipient becomes a body donor. (Petrowsky H, Kaldas F, Peacock W, Fisher D, Hong JC, Lassman C, Busuttil RW) Liver Transpl 2013 Jan;19(1):110-2 PMID 23086865
  • Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. (Kulik LM, Fisher RA, Rodrigo DR, Brown RS Jr, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS, A2ALL Study Group) Am J Transplant 2012 Nov;12(11):2997-3007 PMID 22994906
  • Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. (Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, Zarrinpar A, Petrowsky H, Farmer D, Yersiz H, Xia V, Hiatt JR, Busuttil RW) Ann Surg 2012 Oct;256(4):624-33 PMID 22964732
  • Pretransplant neurological presentation and severe posttransplant brain injury in patients with acute liver failure. (Tan WF, Steadman RH, Farmer DG, Hong JC, Busuttil RW, Apinyachon W, Xia VW) Transplantation 2012 Oct 15;94(7):768-74 PMID 22936036
  • What is the prognosis after retransplantation of the liver? (Zarrinpar A, Hong JC) Adv Surg 2012;46:87-100 PMID 22873034
  • Simultaneous liver-kidney transplantation summit: current state and future directions. (Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS) Am J Transplant 2012 Nov;12(11):2901-8 PMID 22822723
  • Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. (Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK) Gastroenterology 2012 Jul;143(1):88-98.e3; quiz e14 PMID 22504095
  • Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma. (Rana A, Hong JC) Curr Opin Gastroenterol 2012 May;28(3):258-65 PMID 22333563
  • Regulated hepatic reperfusion mitigates ischemia-reperfusion injury and improves survival after prolonged liver warm ischemia: a pilot study on a novel concept of organ resuscitation in a large animal model. (Hong JC, Koroleff D, Xia V, Chang CM, Duarte SM, Xu J, Lassman C, Kupiec-Weglinski J, Coito AJ, Busuttil RW) J Am Coll Surg 2012 Apr;214(4):505-15; discussion 515-6 PMID 22321520
  • There's more than 1 way to split a liver and skin a cat. (Rana A, Hong JC) Arch Surg 2011 Sep;146(9):1059-60 PMID 22029068
  • Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. (Hong JC, Yersiz H, Kositamongkol P, Xia VW, Kaldas FM, Petrowsky H, Farmer DG, Lipshutz G, Markovic D, Hiatt JR, Busuttil RW) Arch Surg 2011 Sep;146(9):1017-23 PMID 21930997
  • Predictive index for long-term survival after retransplantation of the liver in adult recipients: analysis of a 26-year experience in a single center. (Hong JC, Kaldas FM, Kositamongkol P, Petrowsky H, Farmer DG, Markovic D, Hiatt JR, Busuttil RW) Ann Surg 2011 Sep;254(3):444-8; discussion 448-9 PMID 21817890
  • Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. (Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW) Arch Surg 2011 Jun;146(6):683-9 PMID 21690444
  • Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. (Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE) Hepatology 2011 Oct;54(4):1313-21 PMID 21688284
  • Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors. (Saab S, Bownik H, Ayoub N, Younossi Z, Durazo F, Han S, Hong JC, Farmer D, Busuttil RW) Liver Transpl 2011 May;17(5):580-90 PMID 21506246
  • Where are we today in split liver transplantation? (Hong JC, Yersiz H, Busuttil RW) Curr Opin Organ Transplant 2011 Jun;16(3):269-73 PMID 21467935
  • Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. (Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW) J Am Coll Surg 2011 Apr;212(4):514-20; discussion 520-1 PMID 21463781
  • Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study. (Chen J, Singhapricha T, Hu KQ, Hong JC, Steadman RH, Busuttil RW, Xia VW) Transplantation 2011 Feb 15;91(3):348-53 PMID 21127462
  • Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. (Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, Venick RS, Feist S, Goldstein L, Saab S, Hiatt JR, Busuttil RW) Ann Surg 2010 Oct;252(4):652-61 PMID 20881772
  • Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management. (Desai S, Hong JC, Saab S) Liver Int 2010 Aug;30(7):948-57 PMID 20500807
  • Current status of donation after cardiac death liver transplantation. (Reich DJ, Hong JC) Curr Opin Organ Transplant 2010 Jun;15(3):316-21 PMID 20414112
  • Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. (Gillespie BW, Merion RM, Ortiz-Rios E, Tong L, Shaked A, Brown RS, Ojo AO, Hayashi PH, Berg CL, Abecassis MM, Ashworth AS, Friese CE, Hong JC, Trotter JF, Everhart JE, A2ALL Study Group) Am J Transplant 2010 Jul;10(7):1621-33 PMID 20199501
  • Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. (Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, Fisher RA, Trotter JF, Brown RS Jr, Terrault NA, Hayashi PH, Hong JC, A2ALL Study Group) Ann Surg 2010 Mar;251(3):542-9 PMID 20130466
  • Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. (Petrowsky H, Hong JC) Transplant Proc 2009 Dec;41(10):4023-35 PMID 20005336
  • Predictors of survival following liver transplantation in infants: a single-center analysis of more than 200 cases. (Venick RS, Farmer DG, McDiarmid SV, Duffy JP, Gordon SA, Yersiz H, Hong JC, Vargas JH, Ament ME, Busuttil RW) Transplantation 2010 Mar 15;89(5):600-5 PMID 19997060
  • Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. (Tong MJ, Chavalitdhamrong D, Lu DS, Raman SS, Gomes A, Duffy JP, Hong JC, Busuttil RW) J Clin Gastroenterol 2010 Mar;44(3):e63-70 PMID 19745756
  • Fulminant hepatic failure in children: superior and durable outcomes with liver transplantation over 25 years at a single center. (Farmer DG, Venick RS, McDiarmid SV, Duffy JP, Kattan O, Hong JC, Vargas J, Yersiz H, Busuttil RW) Ann Surg 2009 Sep;250(3):484-93 PMID 19730179
  • Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. (Duffy JP, Hong JC, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, Busuttil RW) J Am Coll Surg 2009 May;208(5):896-903; discussion 903-5 PMID 19476857
  • Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases. (Hong JC, Yersiz H, Farmer DG, Duffy JP, Ghobrial RM, Nonthasoot B, Collins TE, Hiatt JR, Busuttil RW) J Am Coll Surg 2009 May;208(5):682-9; discusion 689-91 PMID 19476815
  • Does race influence outcomes after primary liver transplantation? A 23-year experience with 2,700 patients. (Hong JC, Kosari K, Benjamin E, Duffy JP, Ghobrial RM, Farmer DG, Yersiz H, Xu J, Hiatt JR, Busuttil RW) J Am Coll Surg 2008 May;206(5):1009-16; discussion 1016-8 PMID 18471745
  • Cold ischemia time and liver graft survival. (Hong JC, Busuttil RW) Am J Transplant 2008 Mar;8(3):481-2 PMID 18261167
  • Early perioperative outcomes and pancreaticoduodenectomy in a general surgery residency training program. (Fischer CP, Hong JC) J Gastrointest Surg 2006 Apr;10(4):478-82 PMID 16627211
  • Method of pyloric reconstruction and impact upon delayed gastric emptying and hospital stay after pylorus-preserving pancreaticoduodenectomy. (Fischer CP, Hong JC) J Gastrointest Surg 2006 Feb;10(2):215-9 PMID 16455453
  • Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene. (Hong ME, Hong JC, Stepkowski S, Kahan BD) Transplant Proc 2005 Dec;37(10):4254-8 PMID 16387092
  • Sirolimus rescue therapy for refractory rejection in renal transplantation. (Hong JC, Kahan BD) Transplantation 2001 Jun 15;71(11):1579-84 PMID 11435968
  • A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function. (Hong JC, Kahan BD) Transplantation 2001 May 15;71(9):1320-8 PMID 11397971
  • Sirolimus rescue therapy for refractory rejection in renal transplant recipients. (Hong JC, Kahan BD) Transplant Proc 2001 Feb-Mar;33(1-2):1033 PMID 11267178
  • A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation. (Hong JC, Kahan BD) Transplant Proc 2001 Feb-Mar;33(1-2):1271-2 PMID 11267288
  • Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report. (Chueh SC, Hong JC, Huang CY, Lai MK) Transplant Proc 2000 Nov;32(7):1925-6 PMID 11120003
  • Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management. (Hong JC, Kahan BD) Transplantation 2000 May 27;69(10):2085-90 PMID 10852601
  • New immunosuppressive agents. (Katz SM, Hong JC, Kahan BD) Transplant Proc 2000 May;32(3):620-1 PMID 10812142
  • Immunosuppressive agents in organ transplantation: past, present, and future. (Hong JC, Kahan BD) Semin Nephrol 2000 Mar;20(2):108-25 PMID 10746855
  • Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression. (Hong JC, Kahan BD) Transplantation 1999 Sep 15;68(5):701-4 PMID 10507492
  • Last update: 02/27/2015